AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
250.94
-6.47 (-2.51%)
At close: Jul 31, 2026, 4:00 PM EDT
251.85
+0.91 (0.36%)
After-hours: Jul 31, 2026, 7:59 PM EDT

AbbVie Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,6414,2334,2864,87311,84511,549
Depreciation & Amortization
8,0368,1398,3868,6988,4678,521
Stock-Based Compensation
989955911747671692
Other Adjustments
9,4158,0658,0055,7084,0543,246
Change in Receivables
76-1,49020766-1,455-1,321
Changes in Inventories
-263-234-319-417-686-142
Changes in Income Taxes Payable
-1,221-762-3,208-488542-1,290
Changes in Other Operating Activities
-2961245383,6521,5051,522
Operating Cash Flow
21,22419,03018,80622,83924,94322,777
Operating Cash Flow Growth
29.41%1.19%-17.66%-8.43%9.51%29.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,244-1,214-974-777-695-787
Purchases of Investments
--35-73-77-1,438-119
Proceeds from Sale of Investments
-76555551,53098
Cash Acquisitions
-5,169-5,441-20,517-1,223-794-1,902
Other Investing Activities
-88-2918913774366
Investing Cash Flow
-6,482-6,643-20,820-2,009-623-2,344

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-4,7985,008---
Short-Term Debt Repaid
--2,798-5,008---
Net Short-Term Debt Issued (Repaid)
-2,0000---
Long-Term Debt Issued
7,9913,99416,963-2,0001,000
Long-Term Debt Repaid
-3,771-6,797-9,613-4,149-14,433-9,414
Net Long-Term Debt Issued (Repaid)
4,220-2,8037,350-4,149-12,433-8,414
Issuance of Common Stock
-172214180262244
Repurchase of Common Stock
-1,508-980-1,708-1,972-1,487-934
Net Common Stock Issued (Repurchased)
-1,508-808-1,494-1,792-1,225-690
Common Dividends Paid
-11,818-11,657-11,025-10,539-10,043-9,261
Other Financing Activities
-1,554544-42-742-1,102-674
Financing Cash Flow
-10,547-12,724-5,211-17,222-24,803-19,039

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2142-655-62-97
Net Cash Flow
4,216-295-7,2903,613-5451,297

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
19,98017,81617,83222,06224,24821,990
Free Cash Flow Growth
29.87%-0.09%-19.17%-9.01%10.27%30.97%
FCF Margin
31.81%29.13%31.65%40.62%41.77%39.13%
Free Cash Flow Per Share
11.2710.0510.0612.4413.6412.37
Levered Free Cash Flow
12,8679,47616,05111,3828,53610,952
Unlevered Free Cash Flow
14,35515,72614,96220,61425,05623,761
SEC Filings: 10-K · 10-Q